China vs Netherlands: New cases tested for RR-/MDR-TB
China
91.0%
in 2024
Netherlands
91.0%
in 2024
China rank
91st
Netherlands rank
91st
New cases tested for RR-/MDR-TB over time
- China
- Netherlands
How they compare
China currently reports 91.0% against 91.0% in Netherlands, a difference of 0.0%.
Across all 15 years both countries report, Netherlands has been ahead every year.
China ranks 91st and Netherlands ranks 91st of 192 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | China | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.1% | 100.0% | 100.0% | Netherlands |
| 2010s | 32.4% | 95.6% | 63.1% | Netherlands |
| 2020s | 85.0% | 89.0% | 4.0% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, China or Netherlands?
- China, at 91.0% against 91.0% in Netherlands as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between China and Netherlands?
- 0.0%, with China ahead.
- How many years of comparable data are there for China and Netherlands?
- 15 years are reported by both, from 2006 to 2024.
- How do China and Netherlands rank globally for new cases tested for rr-/mdr-tb?
- China ranks 91st and Netherlands ranks 91st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.